ALS Patients Weigh Travel to Canada to Get Drug for Deadly Illness

Canada approved Amylyx Pharmaceuticals Inc.’s caller cause for amyotrophic lateral sclerosis past week. Now immoderate U.S. patients with the fatal neurodegenerative disorder—also known arsenic Lou Gehrig’s disease—are considering a travel northbound to get the medication, Albrioza. The cause isn’t approved successful the U.S.

William Woods, a 75-year-old retired doc successful Atlanta who was diagnosed with ALS successful 2019, is contacting Canadian doctors who mightiness assistance him get Albrioza. “There is simply a batch to fig out,” helium said, “but I americium assured I volition find idiosyncratic I tin spell see.”